Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

E Viehl, A Lichvar, C Chan… - Transplant Infectious …, 2022 - Wiley Online Library
Background Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

E Viehl, A Lichvar, C Chan, D Choi - Transplant Infectious Disease, 2022 - ncbi.nlm.nih.gov
Background Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.

E Viehl, A Lichvar, C Chan, D Choi - 2022 - cabidigitallibrary.org
Background: Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.

E Viehl, A Lichvar, C Chan… - Transplant Infectious …, 2022 - search.ebscohost.com
Background: Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.

E Viehl, A Lichvar, C Chan, D Choi - Transplant Infectious Disease …, 2022 - europepmc.org
Background Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

E Viehl, A Lichvar, C Chan… - … infectious disease: an …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …

[引用][C] Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

E Viehl, A Lichvar, C Chan, D Choi - 2021 ACCP VIRTUAL …, 2021 - accp.confex.com

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.

E Viehl, A Lichvar, C Chan, D Choi - Transplant Infectious Disease …, 2022 - europepmc.org
Background Cytomegalovirus (CMV) is a common opportunistic infection in patients after
liver transplant (LT). Guidelines recommend 900 mg daily of valganciclovir; however …